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Abstract
Amelogenesis imperfecta (AI) is a genetically heterogeneous group of diseases that result in
defective development of tooth enamel. Mutations in several enamel proteins and proteinases have
been associated with AI. The object of this study was to evaluate evidence of etiology for the six
major candidate gene loci in two Brazilian families with AI. Genomic DNA was obtained from family
members and all exons and exon-intron boundaries of the ENAM, AMBN, AMELX, MMP20, KLK4
and Amelotin gene were amplified and sequenced. Each family was also evaluated for linkage to
chromosome regions known to contain genes important in enamel development. The present
study indicates that the AI in these two families is not caused by any of the known loci for AI or
any of the major candidate genes proposed in the literature. These findings indicate extensive
genetic heterogeneity for non-syndromic AI.
Background
Amelogenesis imperfecta (AI) is a group of inherited
defects of dental enamel formation that show both clini-
cal and genetic heterogeneity [1]. In its mildest form, AI
causes discoloration, while in the most severe presenta-
tion the enamel is hypocalcified causing it to be abraded
from the teeth shortly after their emergence into the
mouth [2]. Both the primary and permanent dentitions
may be affected. Enamel findings in AI are highly variable,
ranging from deficient enamel formation to defects in the
mineral and protein content [3]. Four main types of AI
have been described: hypoplastic, hypocalcified,
hypomaturation and hypomaturation-hypoplastic with
taurodontism [4].
The AI phenotypes vary widely depending on the specific
gene involved, the location and type of mutation, and the
corresponding putative change at the protein level [5].
Different inheritance patterns such as X-linked, auto-
somal dominant and autosomal recessive types have been
reported and 14 subtypes of AI are recognized [4].
The distribution of AI types is known to vary in different
populations [3], suggesting allele frequency differences
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between ethnic groups [6]. The combined prevalence of
all forms of AI has been reported as 1:14000 in the U.S.
[7], 1:8000 in Israel [6] and 1:4000 in Sweden [8]. The
autosomal dominant form of AI is most prevalent in the
United States and Europe, while autosomal recessive AI is
most prevalent in the Middle East [6,7]. Different muta-
tions in genes that encode principal matrix proteins and
proteinases of enamel have been associated with the dif-
ferent phenotypes of AI.
The main structural proteins in forming enamel are amel-
ogenin, ameloblastin, and enamelin. These proteins are
proteolytically cleaved following their secretion. Some of
the cleavage products accumulate in the enamel layer,
while others are either degraded or reabsorbed by amelob-
lasts [9]. Different proteinases such as matrix metallopro-
teinase-20 and kallikrein-4, regulate the enamel matrix
protein processing that ultimately defines the structure
and composition of enamel [10].
Amelogenin, the protein product of the AMELX Xp22.3-
p22.1 and AMELY Yp11 genes, is considered to be critical
for normal enamel thickness and structure [11]. Amelo-
genin is the most abundant protein in developing enamel,
accounting for more than 90% of total enamel protein
[12], while ameloblastin and enamelin account for about
5% and 2% of total protein, respectively [9]. Amelogenin
is thought to form a scaffold for enamel crystallites and to
control their growth [11], but its exact functions are not
fully known [13]. At least 14 mutations have been
described in the X-chromosome amelogenin gene and are
associated with hypoplastic and/or hypomineralization
AI [12-19]. However, no cases of mutation in the Y-chro-
mosome amelogenin gene have been reported [13], due
to the fact that, the amino acid sequence of the X and Y
chromosome amelogenin genes are not the same and
only the X copy is critical for normal enamel develop-
ment.
The chromosome 4q13 region contains at least 3 genes
important in enamel development: enamelin, ameloblas-
tin, and amelotin. Enamelin gene mutations have been
identified in autosomal dominant AI [1,5,20,21].
Recently it was reported that transgenic mice overexpress-
ing ameloblastin develop AI [22]. In ameloblastin null
mutant mice, ameloblasts regain some early phenotypes
of undifferentiated dental epithelial cells, and the abnor-
malities occur when the cells detach indicating that amel-
oblastin is an adhesion molecule key for enamel
formation [23].
Recently a novel gene coding for an ameloblast-specific
protein, amelotin, was mapped close to the amelobastin
and enamelin genes. It was hypothesed that amelotin is
involved primarily in the maturation of enamel and thus
the formation of its unique biomechanical characteristics
during tooth development [24,25].
Mutations in the predominant enamel proteinases [9]
have also been associated with AI. MMP20 is secreted into
the enamel matrix in the secretory and transition develop-
mental stages [10,26,27]. This enzyme accounts for most
of the proteolytic activity of the enamel matrix and is
thought to be responsible for the processing of the amel-
ogenin protein causing the tyrosine-rich amelogenin pep-
tide (TRAP) to form [28,29]. Kallikrein-4 is thought to be
the major enzyme responsible for the degradation of
enamel proteins during the maturation stage, and has
been shown to cleave amelogenin [30]. The human
MMP20 and KLK4 genes map to chromosome 11 and 19,
respectively [31]. Two different mutations in MMP20 gene
and one in KLK4 gene confirm that mutations in theses
genes have been associated with autosomal-recessive
forms of AI [32,33].
The purpose of this study was to evaluate evidence for a
genetic etiology for the six major candidate gene loci
(ENAM, AMBN, AMELX, MMP20, KLK4, Amelotin) in
two Brazilian families segregating AI. All exons and
intron-exon junctions of these genes were sequenced, and
polymorphic DNA loci spanning candidate genes in seven
chromosomal regions were genotyped to evaluate support
for linkage. Results of these studies provide further evi-
dence for genetic heterogeneity of AI.
Materials and methods
Family and phenotype analyses
This study was carried out with the approval of the FOP/
UNICAMP Ethics Committee (protocol 127/03) and
informed consent was obtained from all subjects. Two
families segregating AI were identified. All available fam-
ily members were examined clinically and in some cases
radiographically. Oral examinations included visual
examination in a dental clinic using artificial light and
dental mirror evaluations of teeth and supporting tissues.
Affected and unaffected individuals were also evaluated
clinically for the presence of skin, hair, fingernail and
osseous abnormalities know to be associated with sys-
temic or syndromic conditions that can be associated with
enamel defects. No history of nutritional disturbances was
reported by the affected members of the two families.
Affected status of family 1 was established clinically by the
presence of a generalized yellow-brown discoloration of
primary and permanent dentitions. The deficiency in the
enamel mineral content was evidenced by a lack of radio-
graphic enamel opacity and a pathological loss of enamel
through wear and fracturing. The clinical phenotype and
family history suggested an autosomal recessive hypocal-
cified AI (Fig 1).Head & Face Medicine 2007, 3:8 http://www.head-face-med.com/content/3/1/8
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The enamel of affected members of family 2 was thin with
rough and pitted surface (hypoplastic AI, Family 2). Both
primary and permanent dentitions were affected. The clin-
ical phenotype and family history did not allow determin-
ing the pattern of gene inheritance (Fig 2).
Blood was obtained by venepuncture (Vacutainer system)
and DNA extracted using Kit Puregene (Gentra Systems)
for genotyping and sequence analysis.
Genotyping studies
Members of each family were evaluated for linkage to
chromosomal regions known to contain genes important
in enamel development at previously described [24,32-
38]. Table 1 shows studied markers for linkage to chromo-
some regions known to contain genes important in
enamel development. The PCR reactions were performed
using 20 ng of genomic DNA in a final volume of 7.5 μl,
as reported previously [39]. All electrophoretic evalua-
tions of the marker gene allele sizes were performed on an
ABI 3100XL automated DNA sequencer using POP-7, 37
cm capillary and an internal size standard (ROX GS 400
standard (Applied Biosystems, Foster City, CA, USA)).
Allele calling was done using the genescan software
(Applied Biosystems, Foster City, CA, USA).
Mutation analysis
PCRs were carried out in a Perkin-Elmer GeneAmp 2400
thermal cycler and total volume of 50 μl, containing 500
ng genomic DNA, 10 mM Tris-HCl (pH 8,3), 50 mM KCl,
1.5 mM MgCl2, 1 μM of each primer, 200 mM each
dNTPs, and 1 units Taq DNA polymerase (Amersham
Pharmacia Biotech AB, Uppsala, Sweden). PCR was per-
formed by an initial denaturation at 95°C for 5 min, fol-
lowed by 35 cycles of 1 min at 95°C, annealing for 1 min
at temperature listed in Table 2, extension at 72°C for 1
min, and a final extension at 72°C for 7 min. The primer
sequences and PCR conditions are shown in Table 2.
The PCR products were electrophoresed through 1% aga-
rose gels and the amplicons extracted using GFX™ PCR
DNA and Gel Band Purification Kit (Amersham Pharmacia
Clinical phenotype and pedigree of Family 1 Figure 1
Clinical phenotype and pedigree of Family 1. Family 1: A phenotype demonstrating generalized yellow-brown discolora-
tion of the dentition (A1 patient III-2, A2 patient III-5); B X-ray showing lack of enamel opacity and a pathological loss of enamel 
(B1 patient III-2, B2 patient III-5); C pedigree of Family 1.Head & Face Medicine 2007, 3:8 http://www.head-face-med.com/content/3/1/8
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Biotech). Extracted amplicons were sequenced using do Big
Dye Terminator Kit (Perkin Elmer) and an ABI Prism 377
DNA Sequencer™.
Results and Discussion
Examinations of all affected and unaffected members
from both families studied indicated 4 of the 17 family
members evaluated were affected (2 members affected in
each family). Affected individuals showed no signs of syn-
dromic conditions or systemic illnesses associated with
defective enamel development. None of the unaffected
family members had generalized enamel defects clinically
and showed no evidence of radiographic enamel defects,
taurodontism or dental abnormalities. There was variabil-
ity in the severity of expression of the AI phenotype in
family 2. Individual III-4 of family 2 showed more severe
pitting than his mother (individual II-6). This difference
in severity between males and females may be indicative
of X-linked AI form. The presence of only one male and
one female affected, however, did not allow confirming
this pattern of inheritance. Additionally sequencing of
amelogenin X gene did not reveal any mutations in this
gene that could be associated with enamel phenotype.
Radiographically, enamel was very thin but in some areas
it was possible to note that enamel displayed a radioden-
sity similar to that of normal enamel (Fig. 2).
Affected individuals of family 1 reported variable dental
hypersensitivity ranging from mild dental discomfort
with thermal or chemical stimulation to normal dental
sensitivity. Radiographically the teeth displayed enamel
that had a radiodensity similar to that of dentin (Fig. 1).
A number of genes involved in enamel formation have
been identified, and based on their expression and func-
tion, several of these genes have been proposed as candi-
dates for AI. This study all available family members were
genotyped for multiple short tandem repeat polymor-
phism (STRP) type markers spanning each AI candidate
gene locus. Haplotyped genotype results did not show
support for linkage to any of the chromosomal regions
tested, clearly rejecting the linkage hypothesis throughout
all six candidate regions.
The exons and intron/exon junctions of the AMELX,
ENAM, AMBN, MMP20, KLK4 and Amelotin genes were
sequenced and no gene mutations were identified in any
individuals. A novel polymorphism was identified in the
amelotin gene next exon 5 this gene. This SNP is charac-
Table 1: Markers for linkage to chromosome regions known to contain genes important in enamel development
Markers Label ASR Markers Label ASR Markers Label ASR
D1S252 VIC 86–112 D19S902 FAM 237–273 DXS1060 NED 244–268
D1S498 NED 187–209 D19S904 FAM 213–229 DXS8051 NED 104–134
D1S305 FAM 156–176 D19S246 FAM 185–233 DXS987 FAM 267–293
D1S1153 VIC 270–404 D19S571 NED 289–319 DXS1226 NED 280–302
D4S719 FAM 250–300 D20S117 FAM 151–187 DXS1214 VIC 284–298
AMBN VIC 250–280 D20S889 FAM 87–123 DXS1068 VIC 244–264
922H22 NED 350 D20S115 NED 234–246 DXS993 FAM 267–293
D4S2964 FAM 120 D20S186 VIC 113–139 DXS991 NED 313–341
D7S284 HEX 272–307 D20S112 FAM 213–237 DXS986 FAM 151–181
D7S272 VIC 211–261 D20S195 FAM 128–154 DXS990 FAM 122–132
D7S1837 FAM 193–210 D20S107 FAM 197–221 DXS1106 VIC 126–140
D7S1743 VIC 88–188 D20S178 NED 179–195 DXS8055 VIC 312–324
D11S898 FAM 141–165 D20S196 NED 259–295 DXS1001 VIC 191–211
D11S1391 TET 158–178 D20S100 VIC 209–235 DXS1047 VIC 156–172
D11S1347 HEX 177–203 D20S171 VIC 127–155 DXS1227 FAM 79–99
D11S908 VIC 172–190 D20S173 VIC 128–182 DXS8043 NED 146–180
D11S4090 FAM 161–189 DXS8091 VIC 80–102
DXS1073 FAM 306–334
ASR: Allele Size Range (base pairs)
Clinical phenotype and pedigree of Family 2 Figure 2
Clinical phenotype and pedigree of Family 2. Family 2: 
A phenotype of patient III-4 demonstrating points of yellow-
brown discoloration of the dentition, and areas with thin 
enamel. (A1 dentition, A2 detail); B radiographic patient III-4; 
C pedigree of Family 2 suggested X-link AI.Head & Face Medicine 2007, 3:8 http://www.head-face-med.com/content/3/1/8
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terized by a change of A to G in base 7125
(NCBI35:4:71564458:71579819:1). However, this SNP
does not change the amino acid coded for by the triplet
codon sequence and, therefore, does not appear to be
associated with AI in the studied families. Figure 3 shows
the position of this polymorphism.
While we did not find exon mutations, it is possible that
others types of mutations may be involved, such as pro-
moter or intron mutations or deletions that encompass
whole exons. However, results of the genotyping analyses
do not support genetic linkage to the interval, suggesting
that theses regions are not involved with AI in the studied
families.
Others failed to show association between mutation in
known genes involved in enamel formation and AI [40].
It has been known for some time that defects in known
and suspected candidate genes can not explain all AI cases.
Kim et al. (2006) [41] showed that the current list of AI
Table 2: The primer sequences and PCR conditions
Gene Primer (5' – 3') AT bp Gene Primer (5' – 3') AT bp
MMP20 F: AAGTGCAAACGTGCACTGTC 68°C ENAM F: GAGACTTGACTTGACAGCTCCTAT 60°C
Exon 1 R: GGTTTTCTAGGGCAGAGGAG 170 Exon 1 R: TCTCTAATACTCACCCAATGCC 413
MMP20 F: ACTACGCTGTAGACGCGTCA 58°C ENAM F: CAAAGACAAGCTAACAAAGTTCAA 58°C
Exon 2 R: CTCTGAATTTGCAAAGACTTG 318 Exon 1 -3 R: GCCCTCTCAAGTGTATTTCTGACA 735
MMP20 F: GAAAACATGTTCCTTCCGTT 58°C ENAM F: GCAGCTTGAAAACTACCAGATGAT 58°C
Exon 3 R: AGATGGAATCCAAGTACCAC 201 Exon 4 e 5 R: ACTTTGCCTCGATTTGAGAGTTTA 573
MMP20 F: GAAGGACTCAATCTTGTTGGC 62°C ENAM F: CACTGGGAAGTTCTAAGGTT 58°C
Exon 4 R: CCAGGTTATGGTGAATTGTGC 196 Exon 6 R: AACGGAGTTATCTAGATAAACAAG 212
MMP20 F: CCTGTGTTGATACTGTTTTTTTC 60°C ENAM F: CAGCCTGAATCACAGCTCTATT 58°C
Exon 5 R: GGGTGGTCATCAAAGAAGG 234 Exon 7 R: TTAAAAGGCAACAGTATTTGGGTA 513
MMP20 F: CCCGTTACCATTTTGACCAAC 60°C ENAM F: TTATCATTATCGTCTTTGCCCTAT 58°C
Exon 6 R: AATGAGAGTCGGTGGCGTGT 210 Exon 8 R: CCCAGTTTCCCCATTACATT 567
MMP20 F: GTAAATCAATCATTGATCTTG 56°C ENAM F: TCGAAGGTGGTTTTCTCCTGTGTT 58°C
Exon 7 R: GCCATTTCTTTCTTTGAGGG 226 Exon 9 R: AGCAGGGGCGAATGGATTGT 157
MMP20 F: GGTGCAGAGTTTTCGTAAAC 52°C ENAM F: AACACCATGGTGGGAAACAAAG 58°C
Exon 8 R: AAATAAAGATAGATAGTAAAAAGG 232 Exon 10.1 R: TTACGTTCCCAAGCAAAGAAGTTC 573
MMP20 F: CATCTACAACCAGTAAAAACC 58°C ENAM F: ACAGAATAGGCCTTTTTACAGA 60°C
Exon 9 R: GCAAAGCCAAGATTTCTTATG 223 Exon 10.2 R: ATTGGGTTATATTCAGGGTAGAA 787
AMELX F: GGATTGGTTGTTACAGATGCC 59°C ENAM F: CAAGAAGAACATTTACCCCATCCT 60°C
Exon 1 R: TGGGCCAACTAAAAAGTAAC 252 Exon 10.3 R: CATGCCATAGTTCAAATTCTCACC 753
AMELX F: TGTGTTTTATGGAGCATTCA 65°C ENAM F: AGCTGGGCTTCAGAAAAATCCAAT 60°C
Exon 2 R: TTACTCACAGGCATGGCAAAAGCTGC 148 Exon 10.4 R: AGATGGTCTTTGCTGTTGCCTCTC 709
AMELX F: CCTCCCTGTAAAAGCTACCACC 67°C ENAM F: CTCCAATCCAGAAGGCATCCAA 60°C
Exon 3 R: CTTTACAGAGCCCAGGGCATTG 126 Exon 10.5 R: CTCCACCTGGGTCGCTACTCCTAT 510
AMELX F: GTAGAACTCACATTCTCAGGC 67°C KLK4 F: GCAGCTTTGCAGTCACAAGC 58°C
Exon 4e 5 R: AATGTCTACATACCGGTGGCC 292 Exon 1 R: AGGGACAAAGAGAGGGATGG 150
AMELX F: GTAGAACTCACATTCTCAGGC 67°C KLK4 F: TGACTGCTCCTGAACCTCTG 58°C
Exon 6 R: GGCTTCAAAATATACTCACCACTTCC 994 Exon 2 R: ATGAGCCTGATATTAGGCCC 334
AMELX F: CATCTACAACCAGTAAAAACC 67°C KLK4 F: TTCTCCACCCTTCCCTGAGT 58°C
Exon7 R: GCAAAGCCAAGATTTCTTATG 223 Exon 3 e 4 R: TGCCACAAAACTGACCTGCC 555
AMBN F: ATTGCAGGAGCAGAGATTCC 58°C KLK4 F: GAATTCTGACTCTCCCTCTC 58°C
Exon 1 R: TGGGTGTTAGGCATGTCATC 395 Exon 5 R: GGTCAATTTCATGGGTTCCC 214
AMBN F: CCTTTATCCCGGTGGTTTTT 58°C Amelotin F: CTGCAGCTAATAACCCACCTAATGA 58°C
Exon 2 R: CGCTTTTGGATTGCAAGACT 365 Exon 1 e 2 R: AATTGACCTTTTACCACGATGGA 636
AMBN F: CTTCTTCATTCTGCCCAAGC 58°C Amelotin F: GGGCTGGCATTTTTCCACTCTACAT 58°C
Exon 3 R: TGCAGTAGAATTATAAGACAAAGCTC 385 Exon 3 R: TTTTCCCCACTCCCAAACGA 437
AMBN F: TCCACCTTTCAGTGATGATTTG 58°C Amelotin F: CGAGGCTTCATCTTTATTTACCTTC 58°C
Exon 4 R: TTGTTTTTGTTTTTCCCTGTCA 376 Exon 4 R: CATTTGTGGATATACGCACCC 306
AMBN F: CTGGCGACAGAGCAAGATTC 58°C Amelotin F: GCAATAGCCCTTGTAGTCGTAC 58°C
Exon 5 R: TCGATTTATTTGGCACGAGA 370 Exon 5 R: GCATGGTCAGTTCTCTGGGTATGTT 496
AMBN F: TCCTAGCCTCCCTTCCAGAT 58°C Amelotin F: GGCATAGTAGCAGGCAACTGT 58°C
Exon 6 R: TTATGCCTGAAGGCTACGATT 452 Exon 6 R: ACAAAGTACATTGGAAACCTCACAA 358
AMBN F: TTGGGTCATACCTCCCAAAA 58°C Amelotin F: ATAGATCATAAGGCAGTTTAACATATT 58°C
Exon 7–9 R: TCATGGATAAATGGGACAATGA 670 Exon 7 R: TAGAAAAGTAGCTGGAGAAGTATAATG 373
AMBN F: TCATGGATAAATGGGACAATGA 58°C Amelotin F: CTCCATCTTTCCATTCCTACCCA 58°C
Exon 10–12 R: CTGAGTCCCATGATCATTTG 950 Exon 8 R: GAGTAAAAATATTCCCTCATGTTGCT 527
AMBN F: CAGCCAACTTCCTATTCTCCA 58°C Amelotin F: CTAAAGAATGATATGGATGCTCCTAAT 58°C
Exon 13 R: AAAGCAAGAAGGGGACCTACA 842 Exon 9 R: GAGACCAGAATTTGTCTTCACATTGC 567Head & Face Medicine 2007, 3:8 http://www.head-face-med.com/content/3/1/8
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candidate genes was insufficient to identify the causative
gene defect in most families studied, suggesting that
unknown genes/proteins that are critical for dental
enamel formation. Our results indicate that additional
locus coding for genes involved in ameloblast cytodiffer-
entiation and function remain unidentified. Recently,
Mendoza et al. (2006) [42] have mapped a new locus for
autosomal dominant amelogenesis imperfecta on the
long arm of chromosome 8 at 8q24.3.
In this study, exclusion of six candidate genes suggests that
this common AI type is caused by alteration of a gene that
is either not known or not considered to be a major con-
tributor to enamel formation. Continued mutational
analysis of families with AI will allow a comprehensive
standardized nomenclature system to be developed for
this group of disorders that will include molecular deline-
ation as well as a mode of inheritance and phenotype.
Conclusion
The present study indicates that the autosomal recessive
hypocalcified and a hypoplastic form of AI in two distinct
families are not caused by mutations in any of the known
loci for amelogenesis imperfecta. This suggests that many
additional genes potentially contribute to the etiology of
AI.
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